DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sallustio, B. C.
Right arrow Articles by Pannall, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sallustio, B. C.
Right arrow Articles by Pannall, P. R.

0090-9556/97/2501-0055-0060$02.00/0
DRUG METABOLISM AND DISPOSITION
Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics
Vol. 25, No. 1

Interaction of Human Serum Albumin with the Electrophilic Metabolite 1-O-Gemfibrozil-beta -D-Glucuronide

Benedetta C. Sallustio, Barbara A. Fairchild, and Peter R. Pannall

Departments of Clinical Pharmacology (B.C.S., B.A.F.) and Clinical Chemistry (P.R.P.), The Queen Elizabeth Hospital; and the Department of Clinical and Experimental Pharmacology (B.C.S.), University of Adelaide

Acyl glucuronides are electrophilic metabolites that are readily hydrolyzed, undergo intramolecular rearrangement, and bind covalently to endogenous proteins. Gemfibrozil is a fibrate lipid-lowering agent that is extensively metabolized to an acyl glucuronide conjugate in humans. The aims of this study were to examine the interactions of 1-O-gemfibrozil-beta -D-glucuronide with human serum albumin. The degradation of 1-O-gemfibrozil-beta -D-glucuronide (~200 µM) was examined in vitro during incubations at 37°C with phosphate buffer (pH 7.4 or 9.0), solutions of human serum albumin (pH 7.4), or fresh human plasma (pH 7.4). The effects of diazepam, oxyphenbutazone, and gemfibrozil on the degradation of 1-O-gemfibrozil-beta -D-glucuronide, and its reversible binding to albumin were also studied. A pilot in vivo study was performed on two patient volunteers administered 1 g/day po gemfibrozil. 1-O-Gemfibrozil-beta -D-glucuronide was unstable, with degradation half-lives in buffer of 4.1 hr and 44 hr at pH 9.0 and 7.4, respectively; and 8.5 hr and 5.5 hr in pH 7.4 solutions of human serum albumin or fresh plasma, respectively. Degradation was dependent on pH and the presence of albumin, which seemed to accelerate the intramolecular rearrangement and hydrolysis of the conjugate. 1-O-Gemfibrozil-beta -D-glucuronide was highly reversibly bound to albumin, with a mean unbound fraction of 0.028, and its degradation seemed to be related to the degree of reversible binding. Hydrolysis and covalent binding were associated with the site II binding domain on albumin, because only diazepam inhibited these reactions. However, intramolecular rearrangement was increased when binding to the site I domain was inhibited. Covalent binding was also detected in vivo to human plasma proteins. The half-life of the gemfibrozil-protein adducts was 2.5-3 days. Albumin plays an important role in the disposition of acyl glucuronides by acting as: i) a transporter protein; ii) a potential catalyst for their degradation and, therefore, clearance; and iii) a target for covalent adduct formation.


Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
Y. Mano, T. Usui, and H. Kamimura
The UDP-Glucuronosyltransferase 2B7 Isozyme Is Responsible for Gemfibrozil Glucuronidation in the Human Liver
Drug Metab. Dispos., November 1, 2007; 35(11): 2040 - 2044.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J.-S. Wang, M. Neuvonen, X. Wen, J. T. Backman, and P. J. Neuvonen
Gemfibrozil Inhibits CYP2C8-Mediated Cerivastatin Metabolism in Human Liver Microsomes
Drug Metab. Dispos., December 1, 2002; 30(12): 1352 - 1356.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J.-S. Wang, X. Wen, J. T. Backman, and P. J. Neuvonen
Effect of Albumin and Cytosol on Enzyme Kinetics of Tolbutamide Hydroxylation and on Inhibition of CYP2C9 by Gemfibrozil in Human Liver Microsomes
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 43 - 49.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
G. Skopp and L. Potsch
Stability of 11-Nor-{Delta}9-carboxy-tetrahydrocannabinol Glucuronide in Plasma and Urine Assessed by Liquid Chromatography-Tandem Mass Spectrometry
Clin. Chem., February 1, 2002; 48(2): 301 - 306.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Sabordo, B. C. Sallustio, A. M. Evans, and R. L. Nation
Hepatic Disposition of the Acyl Glucuronide1-O-Gemfibrozil-beta -D-Glucuronide: Effects of Dibromosulfophthalein on Membrane Transport and Aglycone Formation
J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 414 - 420.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
M. Wang and R. G. Dickinson
Disposition and Covalent Binding of Diflunisal and Diflunisal Acyl Glucuronide in the Isolated Perfused Rat Liver
Drug Metab. Dispos., February 1, 1998; 26(2): 98 - 104.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.